“Startups need 2-3 times longer to validate their market than most founders expect. This underestimation creates the pressure to scale prematurely”.
This is one of the conclusions of Startup Genome: the largest study ever conducted on startups and its lifecycle. Why do some of them succeed and some not? That’s what Max Marmer and Bjoern Lasse Herrmann, who presented the Startup Genome at Unconvention 2014, wondered when they started researching on it.